1. Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial
    Dina Visca et al, 2018, The Lancet Respiratory Medicine CrossRef
  2. NOX4, MDA, IMA and oxidative DNA damage: can these parameters be used to estimate the presence and severity of OSA?
    Selami Ekin et al, 2021, Sleep and Breathing CrossRef
  3. Intermittent Hypoxemia in Preterm Infants: A Potential Proinflammatory Process
    Elie G. Abu Jawdeh et al, 2021, American Journal of Perinatology CrossRef
  4. Identifying key antioxidative stress factors regulating Nrf2 in the genioglossus with human umbilical cord mesenchymal stem-cell therapy
    Haixian Guo et al, 2024, Scientific Reports CrossRef
  5. Research Status on Biomarkers of Obstructive Sleep Apnea Syndrome
    静 马, 2022, Advances in Clinical Medicine CrossRef
  6. Cardiovascular Disorders Triggered by Obstructive Sleep Apnea—A Focus on Endothelium and Blood Components
    Jakub Mochol et al, 2021, International Journal of Molecular Sciences CrossRef
  7. Upregulation of IL‐8, osteonectin, and myonectin mRNAs by intermittent hypoxia via OCT1‐ and NRF2‐mediated mechanisms in skeletal muscle cells
    Shin Takasawa et al, 2022, Journal of Cellular and Molecular Medicine CrossRef
  8. The administration of rhBmal1 reduces sleep deprivation-induced anxiety and cognitive impairment in mice
    Linqing Qi et al, 2024, The World Journal of Biological Psychiatry CrossRef
  9. The role of NMDA glutamate receptors in lung injury caused by chronic long-term intermittent hypobaric hypoxia
    M.O. Yaman et al, 2023, Brazilian Journal of Medical and Biological Research CrossRef
  10. Sestrin2 in hypoxia and hypoxia-related diseases
    Xiaojing Che et al, 2021, Redox Report CrossRef
  11. Diagnostic Value of Sestrin2 in Patients with Obstructive Sleep Apnea
    Jiagui Chai et al, 2020, Metabolic Syndrome and Related Disorders CrossRef
  12. Daily Intermittent Normobaric Hypoxia Over 2 Weeks Reduces BDNF Plasma Levels in Young Adults – A Randomized Controlled Feasibility Study
    Andreas Becke et al, 2018, Frontiers in Physiology CrossRef
  13. Astragaloside IV ameliorates intermittent hypoxia-induced inflammatory dysfunction by suppressing MAPK/NF-κB signalling pathways in Beas-2B cells
    Jian-Kun Chen et al, 2020, Sleep and Breathing CrossRef